We present a case of Wegener's granulomatosis in which otitis media symptoms masked the disease in first phases. Progressive, unilateral hearing loss, almost deafness, together with facial nerve paresis allowed us to make proper diagnosis and apply therapy.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Calcified Amorphous Tumor and Granulomatosis with Polyangiitis-Case Report and Systematic Review of the Literature.
J Clin Med
December 2024
Department of Cardiac Surgery, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Calcified amorphous tumor (CAT) is a rare, mostly incidental tumor-like cardiac lesion of unknown histogenesis. Current imaging modalities do not differentiate between CAT and other masses. As it can be a source for embolization, surgical excision of CAT is mandatory.
View Article and Find Full Text PDFThis case study of Kongsfjorden, western coastal Svalbard, provides insights on how freshwater runoff from marine- and land-terminating glaciers influences the biogeochemical cycles and distribution patterns of carbon, nutrients, and trace elements in an Arctic fjord system. We collected samples from the water column at stations along the fjord axis and proglacial river catchments, and analyzed concentrations of dissolved trace elements, together with dissolved nutrients, as well as alkalinity and dissolved inorganic carbon. Statistical tools were applied to identify and quantify biogeochemical processes within the fjord that govern the constituent distributions.
View Article and Find Full Text PDF[Granulomatosis with polyangiitis. Analysis of two clinical cases from the practice of an otorhinolaryngologist].
Vestn Otorinolaringol
December 2024
Pavlov Ryazan State Medical University, Ryazan, Russia.
The article presents an analysis of 2 clinical cases of granulomatosis with polyangiitis from the practice of an otorhinolaryngologist. In the first case, the pathology manifested with lesions of the middle ear and nose. In the second case, in addition to manifestations from the nose and the ear, there was a lesion of the larynx.
View Article and Find Full Text PDFA Unique Case Linking Rituximab to a Ureaplasma Infection and Life-Threatening Hyperammonemia.
Cureus
November 2024
Pulmonary & Critical Care, Indiana University Health Methodist Hospital, Indianapolis, USA.
Rituximab is an anti-CD20 monoclonal antibody medication used in treating various cancers like non-Hodgkin lymphomas as well as immunologic conditions like granulomatosis with polyangiitis. It disrupts and decreases the number of B-cells, which causes an immunosuppressive state. This can promote the growth of numerous rare and opportunistic pathogens, one of which is .
View Article and Find Full Text PDFSignal detection and analysis of sulfasalazine adverse reaction events based on the US FDA adverse event reporting database.
Expert Opin Drug Saf
December 2024
Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, The First Dongguan Affiliated Hospital, School of Basic Medical Sciences, Guangdong Medical University, Dongguan, China.
Background: Based on real data from the FDA Adverse Event Reporting System (FAERS), we explored and evaluated the adverse reactions (ADRs) of sulfasalazine (SSZ) in the first quarter of 2004-2023 to provide a reference basis and early warning for the safe use of SSZ in the clinic.
Research Design And Methods: The reporting odds ratio (ROR), the proportional reporting ratio (PRR), the Bayesian confidence propagation neural network (BCPNN), and the empirical Bayesian geometric mean (EBGM) were used as measures of SSZ-associated adverse events (AEs) signals, mining for potential positive signals between SSZ and AE.
Results: In this study, a total of 5327 case reports related to SSZ in the last 20 years involving 25 system organ classes (SOCs) were collected in FAERS.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!